The mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist

Fertility and Sterility

Volumn 93, Issue 5, 2010, Pages 1668-1675

  Taylor, Joelle E ^a,b   Miller, Bradley T ^a,c   Gray, Karen D ^d   Scott Jr , Richard T ^e   Catherino, William H ^c   Segars, James H ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY   (United States)

Author keywords

GnRH receptor; LH surge; LH RH; OHSS; ovarian hyperstimulation syndrome; ovulation induction; pituitary

Indexed keywords

FOLLITROPIN BETA SUBUNIT; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN RECEPTOR; ITURELIX; LEUPRORELIN; LUTEINIZING HORMONE BETA SUBUNIT; MESSENGER RNA; RECEPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GONADOTROPIN RELEASE; HORMONAL REGULATION; HYPOPHYSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SPRAGUE DAWLEY RAT; STORAGE;

ANIMALS; BLOTTING, NORTHERN; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS, PITUITARY; HORMONE ANTAGONISTS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LEUPROLIDE; LUTEINIZING HORMONE, BETA SUBUNIT; OLIGOPEPTIDES; OVARIECTOMY; OVULATION INDUCTION; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LHRH; RNA, MESSENGER;

EID: 77949264357     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.12.047     Document Type: Article

References (43)

1. Schally A.V. Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis. Peptides 20 (1999) 1247-1262
2. Filicori M. Gonadotropin-releasing hormone agonists. A guide to use and selection. Drugs 48 (1994) 41-58
3. Olivennes F. The use of gonadotropin-releasing hormone antagonists in ovarian stimulation. Clin Obstet Gynecol 49 (2006) 12-22
4. Illions E.H., Scott R.T., Carey K.D., and Navot D. Evaluation of the impact of concurrent gonadotropin-releasing hormone (GnRH) antagonist administration on GnRH agonist-induced gonadotrope desensitization. Fert Steril 64 (1995) 848-854
5. Olivennes F., Fanchin R., Bouchard P., Taieb J., and Frydman R. Triggering of ovulation by a gonadotropin-releasing hormone (GnRH) agonist in patients pretreated with a GnRH antagonist. Fertil Steril 66 (1996) 151-153
6. Itskovitz-Eldor J., Kol S., and Mannaerts B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication. Hum Reprod 15 (2000) 1965-1968
7. Fauser B.C., De Jong D., Olivennes F., Wramsby H., Tay C., Itskovitz-Eldor J., et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 87 (2002) 709-715
8. Orvieto R., Zagatsky I., Yulzari-Roll V., La Marca A., and Fisch B. Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less inflammation. Gynecol Endocrinol 22 (2006) 437-440
9. Reissmann T., Felberbaum R., Diedrich K., Engel J., Comaru-Schally A.M., and Schally A.V. Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview. Hum Reprod 10 (1995) 1974-1981
10. Humaidan P., Bredkjaer H.E., Bungum L., Bungum M., Grondahl M.L., Westergaard L., et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 20 (2005) 1213-1220
11. Kolibianakis E.M., Schultz-Mosgau A., Schroer A., van Steirteghem A., Devroey P., Diedrich K., et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of hCG in patients undergoing IVF with GnRH antagonists. Hum Reprod 20 (2005) 2887-2892
12. Griesinger G., von Otte S., Schroer A., Ludwig A.K., Diedrich K., Al-Hasani S., et al. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod 22 (2007) 1348-1352
13. Engmann L., DiLuigi A., Schmidt D., Nulsen J., Maier D., and Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 89 (2008) 84-91
14. Griesinger G., Diedrich K., Devroey P., and Kolibianakis E.M. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta analysis. Hum Reprod 12 (2006) 159-168
15. Beckers N.G., Macklon N.S., Eijkemans M.J., Ludwig M., Felberbaum R.E., Diedrich K., et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab 88 (2003) 4186-4192
16. Conn P.M., and Crowley Jr. W.F. Gonadotropin-releasing hormone and its analogues. N Engl J Med 325 (1991) 93-103
17. Mason D.R., Arora K.K., Mertz L.M., and Catt K.J. Homologous down-regulation of gonadotropin-releasing hormone receptor sites and messenger ribonucleic acid transcripts in alpha T3-1 cells. Endocrinology 135 (1994) 1165-1170
18. Scheele F., Hompes P.G., Lambalk C.B., Schoute E., Broekmans F.J., and Schoemaker J. The GnRH challenge test: a quantitative measure of pituitary desensitization during GnRH agonist administration. Clin Endocrinol 44 (1996) 581-586
19. Halmos G., and Schally A. Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix. Proc Natl Acad Sci USA 99 (2002) 961-965
20. Huirne J.A., and Lambalk C.B. Gonadotropin-releasing-hormone antagonists. Lancet 358 (2001) 1793-1803
21. Tarlatzis B.C., Fauser B.C., Kolibianakis E.M., Diedrich K., and Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod 12 (2006) 333-340
22. Lerrant Y., Kottler M.L., Bergametti F., Moumni M., Blumberg-Tick J., and Counis R. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary. Endocrinology 136 (1995) 2803-2808
23. Kovacs M., and Schally A.V. Comparison of mechanisms of action of luteinizing hormone-releasing (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats. Proc Natl Acad Sci USA 98 (2001) 12197-12202
24. Roth C., Hegemann F., Hildebrandt J., Balzer I., Witt A., Wuttke W., et al. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogs in two peripubertal female rat models. Pediatr Res 55 (2004) 126-133
25. Stojilkovic S.S., Reinhart J., and Catt K.J. Gonadotropin-releasing hormone receptors: structure and signal transduction pathways. Endocr Rev 15 (1994) 462-499
26. Kaiser U.B., Conn P.M., and Chin W.W. Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocr Rev 18 (1997) 46-70
27. Horvath J.E., Bajo A.M., Schally A.V., Kovacs M., Herbert F., and Groot K. Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats. Proc Natl Acad Sci USA 99 (2002) 15048-15053
28. Leal J.A., Gordon K., Williams R.F., Danforth D.R., Roh S.I., and Hodgen G.D. Probing studies on multiple dose effects of antide (NAL-LYS) GnRH antagonist in ovariectomized monkeys. Contraception 40 (1989) 623-633
29. Scott R.T., Illions E.H., Carey K.D., and Navot D. Gonadotropin-releasing hormone antagonist administration enhances gonadotrope responsiveness at doses inadequate to suppress immunoassayable gonadotropin levels. Fertil Steril 64 (1994) 1069-1071
30. Chin W.W., Godine J.E., Klein D.R., Chang A.S., Tan L.K., and Habener J.F. Nucleotide sequence of the cDNA encoding the precursor of the beta-subunit of rat lutropin. Proc Natl Acad Sci USA 80 (1983) 4649-4653
31. Gharib S.D., Roy A., Wierman M.E., and Chin W.W. Isolation and characterization of the gene encoding the b-subunit of rat follicle-stimulating hormone. DNA 8 (1989) 339-349
32. Kaiser U.B., Zhao D., Cardona G.R., and Chin W.W. Isolation and characterization of cDNAs encoding the rat pituitary gonadotropin-releasing hormone receptor. Biochem Biophys Res Commun 189 (1992) 1645-1652
33. Nett T.M., Crowder M.E., Moss G.E., and Duello T.M. GnRH-receptor interaction. V. Down-regulation of pituitary receptors for GnRH in ovariectomized ewes by infusion of homologous hormone. Biol Reprod 24 (1981) 1145-1155
34. Ron-El R., Raziel A., Schachter M., Strassburger D., Kasterstein E., and Friedler S. Induction of ovulation after GnRH antagonists. Hum Reprod Update 6 (2000) 318-321
35. Kol S., and Itskovitz-Eldor J. Severe OHSS: yes, there is a strategy to prevent it!. Hum Reprod 15 (2000) 2266-2267
36. de Jong D., Van Hooren E.G., Macklon N.S., Mannaerts B.M., and Fauser B.C. Pregnancy and birth after GnRH agonist for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report. J Assist Reprod Genet 18 (2001) 30-33
37. Horvath J.E., Toller G.L., Schally A.V., Bajo A.M., and Groot K. Effects of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats. Proc Natl Acad Sci USA 101 (2004) 4996-5001
38. Halmos G., Schally A.V., Pinski J., Vadillo-Buenfil M., and Groot K. Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats for LH-RH antagonist cetrorelix. Proc Natl Acad Sci USA 93 (1996) 2398-2402
39. Murase M., Uemura T., Gao M., Inada M., Funabash T., and Hirahara F. GnRH antagonist-induced down-regulation of the mRNA expression of pituitary receptors: comparisons with GnRH agonist effects. Endocr J 52 (2005) 131-137
40. Roth C., Schricker M., Lakomek M., Strege A., Heiden I., Luft H., et al. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model. J Endocrinol 169 (2001) 361-371
41. Kaiser U.B., Jakubowiak A., Steinberger A., and Chin W.W. Regulation of rat pituitary gonadotropin-releasing hormone receptor mRNA levels in vivo and in vitro. Endocrinology 133 (1993) 931-934
42. Depaolo L.V., Mercado M., Guo Y., and Ling N. Increased follistatin (activin-binding protein) gene expression in rat anterior pituitary tissue after ovariectomy may be mediated by pituitary activin. Endocrinology 132 (1993) 2221-2227
43. Kirk S.E., Dalkin A.C., Yasin M., Haisenleder D.J., and Marshall J.C. Gonadotropin-releasing hormone pulse frequency regulates expression of pituitary follistatin messenger ribonucleic acid: a mechanism for differential gonadotrope function. Endocrinology 135 (1994) 876-880